What are the sexual side effects of ziprasidone (Geodon)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sexual Side Effects of Ziprasidone (Geodon)

Ziprasidone has a lower incidence of sexual side effects compared to many other antipsychotics, making it a favorable option for patients concerned about sexual dysfunction. 1, 2

Overview of Ziprasidone's Sexual Side Effect Profile

  • Ziprasidone is one of the more weight-neutral antipsychotics with fewer metabolic effects, which indirectly benefits sexual function compared to medications that cause significant weight gain and metabolic disturbances 1, 2
  • Unlike many other antipsychotics and SSRIs, ziprasidone does not cause significant persistent effects on prolactin levels, which helps minimize sexual dysfunction 3
  • Ziprasidone has a unique pharmacological profile as a 5-HT1A receptor agonist and antagonist at 5-HT2A, 5-HT2C, and 5-HT1B/1D receptors, which may contribute to its favorable sexual side effect profile 4

Specific Sexual Side Effects

  • Sexual dysfunction with ziprasidone is less common than with many other antipsychotics, particularly those that significantly raise prolactin levels 3
  • In rare cases, ziprasidone has been associated with spontaneous orgasm without sexual arousal, reported in a case study of a bipolar patient - a paradoxical effect not commonly seen with antipsychotics 5
  • When sexual side effects do occur with ziprasidone, they may include:
    • Decreased libido (less common than with other antipsychotics) 1
    • Erectile dysfunction (less frequent than with SSRIs or other antipsychotics) 1
    • Delayed ejaculation or anorgasmia (less common than with SSRIs) 1

Comparison to Other Antipsychotics

  • Ziprasidone tends to have fewer metabolic effects compared to olanzapine, quetiapine, risperidone, and clozapine, which indirectly benefits sexual function 1, 2
  • Aripiprazole and ziprasidone tend to have fewer metabolic effects than other second-generation antipsychotics, making them preferable options when sexual function is a concern 1
  • Haloperidol, clozapine, quetiapine, and risperidone tend to have more metabolic effects that can indirectly impact sexual function 1

Clinical Considerations

  • When prescribing ziprasidone, monitor for the rare occurrence of sexual side effects, but be aware they are less common than with many other antipsychotics 3, 6
  • Ziprasidone must be administered with a 500 kcal meal to ensure proper absorption; inadequate absorption due to improper administration cannot be compensated for by increasing the dose 3
  • The target dose range of 120-160 mg/day is associated with optimal symptom control and greater persistence with treatment 3
  • Monitor for QTc interval prolongation, especially in patients with pre-existing cardiac conditions or those taking other QT-prolonging medications 2, 6

Management of Sexual Side Effects

  • If sexual side effects occur with ziprasidone, consider:
    • Evaluating if the medication is being taken with adequate food (500 kcal meal) 3
    • Assessing for other contributing factors (other medications, medical conditions, psychological factors) 1
    • Adjusting the dose if appropriate while maintaining therapeutic efficacy 3
    • Considering a switch to another antipsychotic with even lower risk of sexual side effects if sexual dysfunction is significantly impacting quality of life 2

Remember that sexual dysfunction is common in patients with psychiatric disorders even before treatment, with studies showing high prevalence rates (50% in men, 68% in women) prior to medication initiation 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Off-Label Uses of Ziprasidone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ziprasidone-induced spontaneous orgasm.

Journal of psychopharmacology (Oxford, England), 2010

Research

Ziprasidone: first year experience in a hospital setting.

Journal of psychiatric practice, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.